1. Home
  2. SWMR vs ARVN Comparison

SWMR vs ARVN Comparison

Compare SWMR & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SWMR

Swarmer Inc Common Stock

N/A

Current Price

$37.09

Market Cap

453.1M

Sector

Technology

ML Signal

N/A

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.05

Market Cap

516.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWMR
ARVN
Founded
2023
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
453.1M
516.2M
IPO Year
2026
2018

Fundamental Metrics

Financial Performance
Metric
SWMR
ARVN
Price
$37.09
$8.05
Analyst Decision
Buy
Analyst Count
0
19
Target Price
N/A
$15.05
AVG Volume (30 Days)
257.7K
535.5K
Earning Date
05-20-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.84
EPS
N/A
N/A
Revenue
N/A
$262,600,000.00
Revenue This Year
$2,862.05
N/A
Revenue Next Year
$177.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.75
$6.06
52 Week High
$83.30
$14.22

Technical Indicators

Market Signals
Indicator
SWMR
ARVN
Relative Strength Index (RSI) 43.67 45.54
Support Level $34.42 $7.90
Resistance Level $38.06 $8.40
Average True Range (ATR) 3.50 0.26
MACD -0.18 -0.00
Stochastic Oscillator 24.01 32.67

Price Performance

Historical Comparison
SWMR
ARVN

About SWMR Swarmer Inc Common Stock

Swarmer Inc is a provider of autonomous drone swarm software and AI solutions, specializing in vendor-agnostic technologies. It develops software platforms and artificial intelligence systems for defence applications, enabling military organisations to deploy and coordinate large-scale unmanned and autonomous systems. Its offerings include swarm coordination software, multi-domain unmanned systems integration, collaborative autonomy solutions, and command-and-control software for distributed robotic operations. Its key software and AI systems include: i) STYX AI Command & Control System, ii) MINAS Autonomy and Collaboration AI and iii) TRIDENT Embedded Drone Operating System. The company generates revenue through software license sales.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: